We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01646021
Brief Title: Study of Ibrutinib (a Bruton's Tyrosine Kinase Inhibitor), Versus Temsirolimus in Patients With Relapsed or Refractory Mantle Cell Lymphoma Who Have Received at Least One Prior Therapy

First Submitted : July 18, 2012
First Submitted that Met QC Criteria : July 18, 2012
First Posted : July 20, 2012 (Estimate)

Results First Submitted : June 2, 2016
Results First Submitted that Met QC Criteria : January 11, 2017
Results First Posted : March 1, 2017

Last Update Submitted that Met QC Criteria : December 15, 2017
Last Update Posted : January 19, 2018